The Tintina fault has triggered many more earthquakes than was thought — and a build-up of strain poses a hazard.

The Trump administration plans the departure for the end of 2026 and criticizes the UN Sustainable Development Goals.

Biogen (BIIB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Second-quarter earnings come amid many high-level challenges for the biopharma industry. How will these five closely watched ...

Durham-based TruTechnologies has secured a strategic growth investment from LLR Partners to accelerate the expansion of its real-time clinical trial oversight solutions and fuel the next phase of ...

Biogen’s $2B RTP expansion highlights a wave of growth in the Triangle, with billions in projects and thousands of jobs on ...

Quarterly Net Profit at Rs. 1.34 crore in June 2025 up 950.06% from Rs. 0.16 crore in June 2024. EBITDA stands at Rs. 1.34 ...